DIASORIN

DIASORIN

DiaSorin S.p.A. develops, manufactures, and distributes immunodiagnostics and molecular diagnostics tests for private and hospital microbiology laboratories worldwide. The company offers testing kits for infectious diseases, such as gastrointestinal infections, bone and mineral metabolism, endocrinology, hypertension, oncology, onco-hematology, and autoimmunity. It also provides various immunodiagnostic platforms, including LIAISON XL, LIAISON XS, LIAISON QuantiFERON TB Gold PLUS, LIAISON Elasta... se-1, and LIAISON MDX. The company sells its products directly, as well as through an international network of independent distributors. DiaSorin S.p.A. has collaboration with QIAGEN to develop an ultra-sensitive diagnostic test for Lyme disease. The company was founded in 1968 and is headquartered in Saluggia, Italy.

DiaSorin_logo

Industry:
Multinational Biotechnology Company

Founded:
1968

Address:
Via Crescentino, Saluggia, VC, Italy Zipcode 13040

Country:
Italy

Phone:
39 01 614871

Company Size Range:
1001 - 5000
Current Employees:
919
Total Employees:
1,759

Market Cap:
8.27B
Total Revenue:
881.3M
Total Assets:
1.25B
Total Cash:
339.88M

Chairman: Gustavo Denegri


Key Executives
Name Title Pay Year Born
Mr. Carlo Rosa CEO, GM & Exec. Director 1,252,000$ 1966(54 years old)
Dr. Chen Menachem Even Chief Commercial Officer, Sr. Corp. VP of Commercial Operations & Exec. Director 605,000$ 1963(57 years old)
Mr. Piergiorgio Pedron Corp. Accounting Documents Officer, CFO & Sr. Corp. VP N/A 1971(49 years old)
Mr. Riccardo Fava Sr. Director of Investor Relations & Corp. Communication N/A N/A
Mr. Marco Minolfo Mang. of the Corp. Legal Affairs Department N/A N/A
Mr. Stefano Ronchi Sr. Corp. VP of HR N/A 1960(60 years old)
Mr. Ugo Gay Sr. Corp. VP of Industrial Operations N/A 1965(55 years old)
Mr. John D. Gerace Pres of DiaSorin Molecular LLC N/A N/A



Financial & Stock
Exchange Milan. Currency in EUR. Market state PREPRE
According to DiaSorin's financial reports the company's revenue in 2020 were 881.3M an increase( +24.79%) over the years 2019 revenue that were of 706.32M. In 2020 the company's total earnings were 247.87M while total earnings in 2019 were 175.74M( +41.14%).
Company's stock symbol is DIA.MI. Lastest price : 151.05. Total volume :259.90k Click reload if you want to check the lastest price on market!!!


Site Inspections: http://www.diasorin.com

  • Host name: 134.213.149.250
  • IP address: 134.213.149.250
  • Location: United Kingdom
  • Latitude: 51.4964
  • Longitude: -0.1224
  • Timezone: Europe/London

Loading ...
Loading ...


More informations about "DiaSorin" on Search Engine

DiaSorin - The Diagnostic Specialist

Diasorin.com Diasorin, The Diagnostic Specialist We are global leader in the laboratory diagnostics market, specializing in the immunodiagnostics and molecular diagnostics segments.

DiaSorin - The Diagnostic Specialist

Diasorin.com Disclaimer: the DIASORIN site content linked here is for United States only. Continue to …

DiaSorin - The Diagnostic Specialist

Diasorin.com Systems | DiaSorin. DiaSorin S.p.A.-Share Capital € 55.948.257 R.E.A. 180729 Fiscal …

DiaSorin - The Diagnostic Specialist

Diasorin.com Diasorin S.p.A. P.IVA 13144290155 Capitale sociale 55.855.439 Euro R.E.A. 180729 …

DiaSorin - The Diagnostic Specialist

Diasorin.com INTERNATIONAL: USA: Disclaimer: the DIASORIN site content linked here is for …

DiaSorin - The Diagnostic Specialist

Diasorin.com DiaSorin is pleased to announce the launch of the new LIAISON® test for the …

DiaSorin - The Diagnostic Specialist

Diasorin.com Products & Solutions | DiaSorin. DiaSorin S.p.A.-Share Capital € 55.948.257 R.E.A. …

DiaSorin - The Diagnostic Specialist

Diasorin.com Open Vacancies | DiaSorin. DiaSorin S.p.A.-Share Capital € 55.948.257 R.E.A. 180729 …

DiaSorin | The Diagnostic Specialist

Diasoringroup.com DiaSorin's new antigen test is an innovative solution that allows patients to get a quick and reliable response on their infection status. This is the fifth test launched by DiaSorin to support laboratories and healthcare systems in containing the spread of SARS-CoV-2.

DiaSorin to Buy Covid-19 Test-Maker Luminex for $1.8

Bloomberg.com 2 days ago · Italian diagnostics company DiaSorin SpA agreed to acquire Luminex Corp. for about $1.8 billion, gaining the maker of Covid-19 testing kits and a greater foothold in the U.S. market. DiaSorin ...

Shares in Italy's DiaSorin jump after $1.8 bln Luminex

Nasdaq.com 1 day ago · Shares in DiaSorin jumped as much as 10% on Monday after the Italian diagnostics group said it was buying U.S. rival Luminex Corp in a $1.8 billion all-cash deal that strengthens its molecular ...

DiaSorin strikes $1.8 billion Luminex deal to dodge 'COVID

Reuters.com 1 day ago · Italian diagnostics firm DiaSorin has agreed to buy U.S. rival Luminex Corp for $1.8 billion in a move that could boost its molecular business and offset a potential drop in demand for COVID-19 ...

Italian diagnostics group DiaSorin to buy Luminex for $1.8 bln

Finance.yahoo.com 2 days ago · (Bloomberg) -- Italian diagnostics company DiaSorin SpA agreed to acquire Luminex Corp. for about $1.8 billion, gaining the maker of Covid-19 testing kits and a greater foothold in the U.S....

DiaSorin - Wikipedia

En.wikipedia.org DiaSorin is an Italian multinational biotechnology company that produces and markets in vitro diagnostics reagent kits used in immunodiagnostics and molecular diagnostics. The group was founded in 2000 and is headquartered in Saluggia, Italy. Its production is at several plants located in Europe and the United States: Saluggia and Gerenzano (Italy), Dietzenbach (Germany), Stillwater, Minnesota (US), Dartford (UK). The company is a constituent of the FTSE Italia Mid Cap index.

DiaSorin to acquire Luminex Corporation for USD 37.00 per

Prnewswire.com 1 day ago · DiaSorin to acquire Luminex Corporation for USD 37.00 per share or approximately USD 1.8 billion IMPORTANT NOTICE. By reading the following release, you further agree to …

Shares in Italy's Diasorin jump after announcing $1.8 bln

Nasdaq.com 1 day ago · Shares in Italy's Diasorin jumped as much as 10% in early trade on Monday after the diagnostics group said on Sunday it will acquire U.S. based …

Diasorin

Catalog.diasorin.com Please select a product line from the sidebar

DiaSorin to acquire Luminex Corporation for USD 37.00 per

Markets.businessinsider.com 1 day ago · NEW DIASORIN'S INVESTOR DAY . Save the date: DiaSorin will host a new Investor Day by the end of September 2021.. ABOUT DIASORIN Headquartered in …

BRIEF-Diasorin To Acquire Luminex For USD 37 Per Share Or

Msn.com April 11 (Reuters) - DiaSorin S.p.A.: * DIASORIN - VIA ACQUISITION, DIASORIN WILL GAIN ACCESS TO LUMINEX’S MOLECULAR DIAGNOSTICS MULTIPLEXING TECHNOLOGY * DIASORIN-COMBINED ENTITY TO HAVE 2020 ...

DiaSorin to Buy Covid-19 Test Maker Luminex for $1.8 Billion

Bloombergquint.com 2 days ago · (Bloomberg) --Italian diagnostics company DiaSorin SpA agreed to acquire Luminex Corp. for about $1.8 billion, gaining the maker of Covid-19 testing kits and a greater foothold in the U.S. market. DiaSorin agreed to pay $37 a share in the all-cash transaction, according to a statement Sunday. That ...

UPDATE 1-Shares in Italy's DiaSorin jump after $1.8 bln

Finance.yahoo.com 1 day ago · Shares in DiaSorin jumped as much as 10% on Monday after the Italian diagnostics group said it was buying U.S. rival Luminex Corp in a $1.8 billion all-cash deal that strengthens its molecular ...

DiaSorin | LinkedIn

Linkedin.com DiaSorin—publicly listed on the FTSE MIB Index since 2007— is an Italy-based company globally operating in laboratory diagnostics. It develops, produces and …

DiaSorin to acquire U.S.-based Luminex for around $1.8

Marketwatch.com 1 day ago · Shares of Italian diagnostic specialist DiaSorin DIA, +6.95% surged 7% on Monday after announcing a deal to buy COVID-19 testing kit maker Luminex Corp. LMNX, +2.08% for …

Diasorin Careers and Employment | Indeed.com

Indeed.com DiaSorin focused its business on improving the health and quality of people’s lives, through high-quality diagnostic products. The DiaSorin and Group’s activities business share a deep-rooted commitment to help people improve the quality of their lives, through the early detection of potential clinical diseases.

Diasorin paying $1.8B to acquire multiplex diagnostic

Bioworld.com 56 minutes ago · Consolidation in diagnostics continues apace, with Diasorin SpA set to take over Luminex Corp. in an all-cash deal that values the multiplex diagnostics and molecular testing specialist at $1.8 billion. At $37 per share, the price is a 23% premium to the Luminex (NASDAQ:LMNX) share price on Feb. 23, which is when rumors of the acquisition began to circulate, and 12% above the close last …

About us | DiaSorin

Diasoringroup.com DiaSorin S.p.A. UK Branch. Central Road, Dartford Kent. DA1 5LRUK. Phone: +44 (0)844 225 8999. Fax: +44 (0)844 225 9888. Germany Dietzenbach. DiaSorin Deutschland GmbH. Von-Hevesy-Straße 3 63128 Dietzenbach. Phone: +49.6074.4010. USA Cypress. DiaSorin Molecular LLC. 11331 Valley View Street Cypress, CA 90630-4717

DiaSorin Weighs Diagnostics Deal for Luminex

Bloombergquint.com Feb 25, 2021 · DiaSorin rose 3.5% to 163.70 euros in Milan, giving the company a market value of about 9.2 billion euros ($11.3 billion). The discussions come as health-care dealmaking picks up, including among companies that make products for dealing with the coronavirus pandemic.

DiaSorin Said to Weigh Deal for Covid-Testing Rival

Bloomberg.com Feb 25, 2021 · DiaSorin is working with advisers to study a potential deal, said the people, who asked to not be identified because discussions are private. No final decision has …

Italy's DiaSorin buys Luminex in $1.8B deal for multiplex

Medtechdive.com 1 day ago · DiaSorin is targeting $55 million in cost savings within three years of the deal closing. The cash deal is funded by debt. Jefferies noted it was a bit expected, with speculation in a Bloomberg article on February 25 and put the offer price at a 23% premium based on Luminex's closing price the day before that news.

Working at DiaSorin | Glassdoor

Glassdoor.com Glassdoor gives you an inside look at what it's like to work at DiaSorin, including salaries, reviews, office photos, and more. This is the DiaSorin company profile. All content is posted anonymously by employees working at DiaSorin.

DiaSorin to acquire Luminex Corporation for USD 37.00 per

Ih.advfn.com 1 day ago · SALUGGIA, Italy, April 11, 2021 /PRNewswire/ -- DiaSorin S.p.A. ("DiaSorin"; FTSE MIB: DIA) today announced that its Board of Directors has unanimously approved and signed a definitive merger agreement for DiaSorin to acquire Luminex Corporation ("Luminex"; NASDAQ: LMNX) for a price of USD 37.00 per share in an all-cash transaction. This corresponds to a total equity value of …

DiaSorin - CodeMap

Codemap.com DiaSorin is not responsible for any actions taken by website users in billing Medicare for DiaSorin products, equipment or devices, including but not limited to, any billing and/or coding errors. Website users rely on the information contained in this website at their own risk and should check with the individual Medicare contractors to verify ...

DiaSorin Arrow Extraction Kits - Fisher Sci

Fishersci.com DiaSorin produces its own reagents for the Arrow systems, which are quality assured in accordance with ISO certified standards. Kits are simple to use: Load tips, tubes and prefilled cartridges and peel foil; Add cell separation beads and elution buffer of your choice; Choose desired protocol and start

Diasorin Molecular LLC Company Profile | Cypress, CA

Dnb.com Diasorin Molecular LLC is located in Cypress, CA, United States and is part of the Diagnostic Substance Manufacturing Industry. Diasorin Molecular LLC has 200 total employees across all of its locations and generates $90.00 million in sales (USD).

Diasorin 1951 Northwestern Ave S Stillwater, MN

Mapquest.com Operational for more than 40 years, DiaSorin is a private company that develops and manufactures reagents for in vitro diagnostics. It offers products for infectious diseases, hepatitis, endocrinology, bone and mineral metabolism, cancer, brain injury, cardiac, therapeutic drug monitoring and autoimmunity.

DiaSorin acquires Luminex for $1.8 billion - CAP TODAY

Captodayonline.com 1 day ago · Through the acquisition, DiaSorin, based in Italy, will gain access to Luminex’s molecular diagnostics multiplexing technology and portfolio, including a menu of solutions in infectious diseases, respiratory infections, vector-borne diseases, hospital-acquired infections, gastroenterology infections, genetics, and women’s health, expanding ...

DIASORIN LTD Company Profile | ROSH HAAYIN, Israel

Dnb.com DIASORIN LTD is located in ROSH HAAYIN, Israel and is part of the Medical Equipment & Supply Wholesalers Industry. DIASORIN LTD has 20 total employees across all of its locations and generates $3.76 million in sales (USD). There are 59 companies in the DIASORIN LTD corporate family.

UPDATE 1-Diagnostics group Diasorin unable to give full

Reuters.com Italian diagnostics group Diasorin said on Thursday it was unable to provide full-year earnings guidance given the uncertainty related to the coronavirus health emergency, after reporting a 39.2% ...

HCP Fact Sheet - Food and Drug Administration

Fda.gov Oct 19, 2020 · DiaSorin Inc. Updated: October 19, 2020 LIAISON® SARS CoV-2 S1/S2 IgG assay Coronavirus Disease 2019 (COVID -19) COVID-19 within the …

Diasorin - CIA Medical

Ciamedical.com Diasorin part numbers 310842 4651 319150 310603 86078 86094X 86045 (86082 86119 86023 86022 86021 7400 310360 310831 310830 310621 310620 310602 310600 310491 310480 310461 310460 86020 85172 85170 86046 85187 85171 86116 86113 86086 86072 86102 86103 86059 86071 86117 86108 86048 86047 86040 86095 86082 86075 86074 7975 88590

DiaSorin S.p.A’s Competitors, Revenue, Number of Employees

Owler.com DiaSorin specializes in provision of developing, producing and commercializing reagent kits for the in vitro diagnostics. DiaSorin S.p.A was founded in 1968. DiaSorin S.p.A's headquarters is located in Saluggia, Other, IT 13040. It has raised undisclo...

Diasorin Jobs, Employment | Indeed.com

Indeed.com 20 Diasorin jobs available on Indeed.com. Apply to Manufacturing Supervisor, Senior Sourcing Manager, Field Applications Scientist and more!

LIAISON XL - DiaSorin - PDF Catalogs | Technical Documentation

Pdf.medicalexpo.com Consult DiaSorin's entire LIAISON XL catalogue on MedicalExpo. Page: 1/13. Disposable Sample Tips and reaction Cuvettes in continuous loading. Sample Area Up to 10 racks with 12 positions each in continuous loading.

Diasorin SpA (DIA) Quote - XMIL | Morningstar

Morningstar.com DiaSorin, headquartered in Italy, is a global provider of in vitro diagnostics--testing done on samples taken from the human body, such as blood and issue. DiaSorin produces and markets testing ...

LIAISON - DiaSorin - PDF Catalogs | Technical Documentation

Pdf.medicalexpo.com Consult DiaSorin's entire LIAISON catalogue on MedicalExpo. Page: 1/6. System Features • Random Access • STAT function SAMPLE LOADING • 144 primary tubes of varying size in racks of 12 samples each • Continuous reloading REAGENT LOADING • 15 assays available, allowing up • Continuous reloading • Reagent cooling REAGENT CONCEPT Reagent Integral • Super paramagnetic …

5-EUA20026 A003 DiaSorin IFU 06022020 (clean 04Jun2020)

Fda.gov ,17(1'(' 86( 7kh 'ld6rulq 0rohfxodu 6lpsoh[d &29,' 'luhfw uhdo wlph 57 3&5 dvvd\ lv lqwhqghg iru xvh rq wkh /,$,621 0'; lqvwuxphqw iru wkh lq ylwur txdolwdwlyh ghwhfwlrq ri qxfohlf dflg iurp ...

DiaSorin and Beckman Coulter Form Strategic Partnership to

Beckmancoulter.com DiaSorin (FTSE Italia Mid Cap: DIA), a global leader in in vitro diagnostics immunoassay specialty testing, and Beckman Coulter Diagnostics, a global developer and manufacturer of clinical diagnostic products, are pleased to announce an agreement to provide customers in the U.S. the LIAISON XL Hepatitis A, B, C and HIV products currently available to DiaSorin customers outside the U.S. territory.

DiaSorin - Posts | Facebook

Facebook.com DiaSorin's new antigen test is an innovative solution that allows patients to get a quick and reliable response on their infection status. This is the fifth test launched by DiaSorin to support laboratories and healthcare systems in containing the spread of SARS-CoV-2 since the beginning of the COVID-19 pandemic worldwide.

DiaSorin To Acquire Focus Diagnostics' Molecular And

Prnewswire.com Mar 30, 2016 · About DiaSorin: Headquartered in Italy and listed in the FTSE Mid Cap Index, DiaSorin is a global leader in the In Vitro Diagnostics (IVD) field. For …